FDA – WHAT NEXT

Tag: FDA

Soft Tissue Sarcoma

March 7, 2024 • Views: 18

Tigilanol Tiglate Granted Orphan Drug Designation for Soft Tissue Sarcoma (STS)

Urothelial Carcinoma

March 6, 2024 • Views: 24

ICYMI: FDA Approves Balversa (Erdafitinib) for Locally Advanced or Metastatic Urothelial Carcinoma

CAR T-Cell Therapy

February 28, 2024 • Views: 19

FDA Requires CAR T-Cell Therapy Boxed Warnings After Reports of Secondary T Cell Malignancies

We’re here for everyone who is affected by cancer. We help people find reliable answers to questions about their disease, support, and life beyond cancer.

Let's Work Together

Site Map

Sign up for our weekly summary of articles and conversation.

↑

Rare Black History: A Childhood Home of Rare Disease… August 31, 2023
Study of the Week: New Method for Personalizing Head… April 17, 2023
Mantle Cell Lymphoma: Not Yet Curable, But This… March 1, 2023
New Investigative Therapy Could Drastically Minimize… March 1, 2023
Researchers Develop Deeper Understanding of Acral… May 16, 2023